MeSH D011213 - poxviridae infections
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D004266:Dna virus infections
0 Companies
0 Drugs
Success rate
D004474:Contagious ecthyma
0 Companies
0 Drugs
Success rate
D004482:Infectious ectromelia
0 Companies
0 Drugs
Success rate
D005586:Fowlpox
0 Companies
0 Drugs
Success rate
D008166:Lumpy skin disease
0 Companies
0 Drugs
Success rate
D009234:Infectious myxomatosis
0 Companies
0 Drugs
Success rate
D012899:Smallpox
D045908:Mpox (monkeypox)
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| SIGA Technologies | Tecovirimat | Tecovirimat SIGA | 2022-01-06 |
Clinical Trials
Historical Success Rate
No data
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use